| Code | 54196 | ||||||||||
| MA number | 44/0570/08-S | ||||||||||
| Product Form: | tbl flm 30x2,5 mg (blis.PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 30.10.2008 |
| PIL: |
PIL_Letrozol Sandoz 2,5 mg_01/2020.doc.doc
|
| SPC: |
SPC_Letrozol_Sandoz 2,5 mg tbl flm_10.2021.pdf
|
| Safety feature | Yes |
| Data update: | 06.10.2021 |
